Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $19.5700 (0.41%) ($19.1000 - $19.6900) on Tue. Dec. 12, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.62% (three month average) | RSI | 52 | Latest Price | $19.5700(0.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.5% a day on average for past five trading days. | Weekly Trend | HALO advances 1.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(57%) IWO(55%) XBI(54%) IWM(51%) ARKG(50%) | Factors Impacting HALO price | HALO will decline at least -1.81% in a week (0% probabilities). VIXM(-12%) UUP(-12%) TLT(-6%) SHY(-4%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.81% (StdDev 3.62%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
5 Day Moving Average | $19.16(2.14%) | 10 Day Moving Average | $18.79(4.15%) | 20 Day Moving Average | $18.7(4.65%) | To recent high | -0.2% | To recent low | 49.8% | Market Cap | $2.675b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |